The Global Emergency Medicine Wiki 13,096 pages with 114,347 recent edits

WikEM, The Global Emergency Medicine Wiki, is the world's largest emergency medicine open-access reference resource. Our highly acclaimed content is freely available via the internet and our dedicated mobile applications. If you are a medical practitioner, join our contributor community and share your important knowledge with the world.

WikEM is a project of the OpenEM Foundation, a 501(c)(3) nonprofit public charity. Please donate to help make open access to medical knowledge possible!

Notes by category Mobile Apps

We need you!

We need you! See something you could improve? Make an edit and help improve WikEM for everyone.


WikEM Recent Changes

With lots of edits happening on the WikEM daily it can be overwhelming to know where to help with edits. Following the recent changes page can help give context.… Read more

Covid19 WikEM consortium

A lot of development has been happening with regards to the Covid19 page and associated pages. Please see here if you would like to help out with efforts… Read more

Stemi and Covid

Updated information for Covid-19 patients with a STEMI. Many hospitals will prefer thrombolytic usage rather than primary PCI in order to limit hospital exposure… Read more


Updates and information regarding covid-19 can be found here.Read more

Antibiotics for diverticulitis

Most providers use Cipro/Flagyl for uncomplicated diverticulitis but don’t forget about alternatives such as Amoxicillin/ClavulanateRead more

Biologic immunomodulators

A quick review of biologic immunomodulators. The various letters chosen in the name indicated the structure, origin, and targets of the molecule. For example ixekizumab for psoriasis ends with –mab, so it is a monoclonal antibody, has a –u- so it is human and has –ki- which means that it is interleukin targeted.

Also, many new novel onocologic agents carry their own adverse effect.s… Read more